Extended Criteria Donors in Liver Transplantation: Adapting Donor Quality and Recipient

Transplantation Proceedings

Volumn 41, Issue 3, 2009, Pages 975-979

  Gastaca, M ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; DONOR SELECTION; FATTY LIVER; GRAFT FAILURE; GRAFT SURVIVAL; HEART DEATH; HEPATITIS B; HEPATITIS C; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECIPIENT;

AGE FACTORS; FATTY LIVER; HUMANS; LIVER TRANSPLANTATION; MIDDLE AGED; PATIENT SELECTION; REGISTRIES; SPAIN; SURVIVAL ANALYSIS; SURVIVORS; TISSUE DONORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 64349120642     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.02.016     Document Type: Article

References (53)

1. Organizacion Nacional de Trasplantes (ONT). http/www.ont.es Accesed on August 10 2008
2. Busuttil R.W., and Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 9 (2003) 651
3. Wiesner R., Edwards E., Freeman R., et al., United Network for Organ Sharing liver disease severity score committee. Model for End-stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 124 (2003) 91
4. Burroughs A.K., Sabin C.A., Rolles K., et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 367 (2006) 225
5. 9th memory of the Registro Español de Trasplantes Hepáticos. http/www.ont.es Accesed on August 10, 2008
6. Adam R., Astarcioglu I., Azoulay D., et al. Liver transplantation from elderly donors. Transplant Proc 25 (1993) 1556
7. Grande L., Rull A., Rimola A., et al. Outcome of patients undergoing orthotopic liver transplantation with elderly donors (over 60 years). Transplant Proc 29 (1997) 3289
8. Grazi G.L., Cescon M., Ravaioli M., et al. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant 1 (2001) 61
9. Gastaca M., Valdivieso A., Pijoan J., et al. Donors older than 70 years in liver transplantation. Transplant Proc 37 (2005) 3851
10. Berenguer M., Prieto M., San Juan F., et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 36 (2002) 202
11. Machicao V.I., Bonatti H., Krishna M., et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 77 (2004) 84
12. Mutimer D.J., Gunson B., Chen J., et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 81 (2006) 7
13. Gastaca M., Fernandez J.R., Valdivieso A., et al. Influence of donor age in HCV recurrence after liver transplantation: very old donors really do worse. Am J Transplant 7 suppl 2 (2007) 876A
14. Alonso O., Loinaz C., Moreno E., et al. Advanced donor age increases the risk of severe recurrent hepatitis C after liver transplantation. Transpl Int 18 (2005) 902
15. Weimann S.U., Satyanarayana A., Tsahuridu M., et al. Hepatocyte telomere shortening and senscence are general markers of human liver cirhosis. FASEB J 16 (2002) 935
16. Segev D.L., Maley W.R., Simpkins C.E., et al. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology 46 (2007) 1907
17. Cameron A.M., Ghobrial R.M., Yersiz H., et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg 243 (2006) 748
18. Feng S., Goodrich N.P., Bragg-Gresham J.L., et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6 (2006) 783
19. D'Alessandro A.M., Kalayoglu M., Sollinger H.W., et al. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc 23 (1991) 1536
20. Rinella M.E., Alonso E., Rao S., et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 7 (2001) 409
21. Fishbein T.M., Fiel M.I., Emre S., et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64 (1997) 248
22. Urena M.A., Riuz-Delgado F.C., Gonzalez E.M., et al. Assesing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 30 (1998) 3288
23. Ploeg R.J., D'Alessandro A.M., Knechtle S.J., et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 55 (1993) 807
24. Verran D., Kusyk T., Painter D., et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 9 (2003) 500
25. Perez-Daga J.A., Santoyo J., Suarez M.A., et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transplant Proc 38 (2006) 2468
26. McCormack L., Petrowsky H., Jochum W., et al. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 246 (2007) 940 discussion 946
27. Adam R., Reynes M., Johann M., et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 23 (1991) 1538
28. Strasberg S.M., Howard T.K., Molmenti E.P., et al. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 20 (1994) 829
29. Chui A.K., Haghighi K., Painter D., et al. Donor fatty (steatotic) liver allografts in orthotopic liver transplantation. Transplant Proc 30 (1998) 3286
30. Briceño J., Padillo J., Rufian S., et al. Assignment of steatotic livers by the Mayo model for end-stage liver disease. Transpl Int 18 (2005) 577
31. Kootstra G., Daemen J.H., and Oomen A.P. Categories of non-heart-beating donors. Transplant Proc 27 (1995) 2893
32. Casavilla A., Ramirez C., Shapiro R., et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 59 (1995) 197
33. Otero A., Gomez-Gutierrez M., Suarez F., et al. Liver transplantation from Maastricht category 2 non-heart-beating donors. Transplantation 76 (2003) 1068
34. Fondevila C., Hessheimer A.J., Ruiz A., et al. Liver transplant using donor after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant 7 (2007) 1849
35. D'Alessandro A.M., Hoffmann R.M., Knetchle S.J., et al. Liver transplantation from controlled non-heart-beating donors. Surgery 128 (2000) 579
36. Foley D.P., Fernandez L.A., Leverson G., et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 242 (2005) 724
37. Fujita S., Mizuno S., Fujikawa T., et al. Liver transplantation from donation after cardiac death: a single center experience. Transplantation 84 (2007) 46
38. Abt P.L., Desai N.M., Crawford M.D., et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 239 (2004) 87
39. Mateo R., Cho Y., Singh G., et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTH/UNOS data. Am J Transplant 6 (2006) 791
40. Testa G., Goldstein R.M., Netto G., et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation 65 (1998) 925
41. Ghobrial R.M., Steadman R., Gornbein J., et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 234 (2001) 384 discussion 393
42. Marroquin C.E., Marino G., Kuo P.C., et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl 7 (2001) 762
43. Khapra A.P., Agarwal K., Fiel M.I., et al. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl 12 (2006) 1496
44. Dodson S.F., Issa S., Araya V., et al. Infectivity of hepatic allografts with antibodies for hepatitis B virus. Transplantation 64 (1997) 1582
45. Nery J., Nery-Avila C., Reddy K., et al. Use of liver grafts from donors positive for anti-hepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis B immunoglobulin and lamivudine. Transplantation 75 (2003) 1179
46. Muñoz J.S. Use of hepatitis B core antibody-positive donors for liver transplantation. Liver Transpl 8 (2002) S82
47. Burton Jr. J.R., and Shaw-Stiffel T.A. Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: a survey of current practice in the United States. Liver Transpl 9 (2003) 837
48. Saab S., Chang A.J., Comulada S., et al. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl 9 (2003) 1053
49. Cuende N., Miranda B., Canon J.F., et al. Donor characteristics associated with liver graft survival. Transplantation 79 (2005) 1445
50. Avolio A.W., Nardo B., Agnes S., et al. The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. Transplant Proc 37 (2005) 2584
51. Maluf D.G., Edwards E.B., and Kauffman H.M. Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the Model for End-stage Liver Disease score of the recipient?. Transplantation 82 (2006) 1653
52. Schnaubel D.E., Sima C.S., Goodrich N.P., et al. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 8 (2008) 419
53. Burra P., and Porte R.J. Should donors and recipients be matched in liver transplantation?. J Hepatol 45 (2006) 488